BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Ainuovirine readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Ainuovirine\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07090889-992@assetmemo.bio
DTSTAMP:20261121T010210Z
DTSTART;VALUE=DATE:20261121
DTEND;VALUE=DATE:20261122
SUMMARY:Ainuovirine: Phase 1 readout est. (NCT07090889)
DESCRIPTION:Ainuovirine\, phase 1.\nStudy: Study of KM-023 in Healthy Volun
 teers and Patients With Olmsted Syndrome.\nEstimated primary completion: 2
 1 November 2026. This is a ClinicalTrials.gov estimate\, not a confirmed r
 eadout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/ainu
 ovirine#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT07090889
URL:https://assetmemo.bio/drug/ainuovirine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07893483-992@assetmemo.bio
DTSTAMP:20261121T010210Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:Ainuovirine: Phase 2 readout est. (NCT07893483)
DESCRIPTION:Ainuovirine\, phase 2.\nStudy: Safety\, Tolerability\, and Effi
 cacy of Oral KM-023 in Adult Patients With Pachyonychia Congenita (pEDD-PC
 )\nEstimated primary completion: April 2027. This is a ClinicalTrials.gov 
 estimate\, not a confirmed readout date\, and it can move.\nDrug page: htt
 ps://assetmemo.bio/drug/ainuovirine#upcoming-events\nRegistry record: http
 s://clinicaltrials.gov/study/NCT07893483
URL:https://assetmemo.bio/drug/ainuovirine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07631897-992@assetmemo.bio
DTSTAMP:20261121T010210Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:Ainuovirine: Phase 4 readout est. (NCT07631897)
DESCRIPTION:Ainuovirine\, phase 4\, HIV.\nStudy: Comparative Trial Between 
 Ainuovirine(ANV)/Lamivudine(3TC)/Tenofovir(TDF) and Efavirenz(EFV)/Lamivud
 ine/Tenofovir Regimens\nEstimated primary completion: June 2028. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/ainuovirine#upcoming-events\nR
 egistry record: https://clinicaltrials.gov/study/NCT07631897
URL:https://assetmemo.bio/drug/ainuovirine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
